Cardinal Health, Inc. (CAH) Debt to Equity Ratio: -3.36
Is Cardinal Health, Inc.’s debt to equity ratio high or low?
Cardinal Health, Inc.'s debt to equity ratio of -3.36 is 259% below its 5-year average of 2.11, near the low end of its 5-year range (-3.36–3.79).
As of Monday, June 15, 2026. 189.12% below its 12-month average of 3.77.
CAH Debt to Equity Ratio Chart
CAH Average Debt to Equity Ratio Chart
CAH Current vs Average Debt to Equity Ratio Chart
CAH Debt to Equity Ratio Metrics
DEBT TO EQUITY RATIO
-3.36
DEBT TO EQUITY RATIO AVG TTM
3.77
DEBT TO EQUITY RATIO AVG 3Y
2.58
DEBT TO EQUITY RATIO AVG 5Y
2.11
DEBT TO EQUITY RATIO AVG 10Y
1.43
DEBT TO EQUITY RATIO AVG 15Y
0.74
DEBT TO EQUITY RATIO AVG 20Y
0.64
CURRENT VS TTM AVG
-189.12%
CURRENT VS 3Y AVG
-230.49%
CURRENT VS 5Y AVG
-258.99%
CURRENT VS 10Y AVG
-335.11%
CURRENT VS 15Y AVG
-556.70%
CURRENT VS 20Y AVG
-626.73%
CAH Competitors' Debt to Equity Ratio
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cardinal Health, Inc. (CAH) | $52.43B | -3.36 | 3.77 | 2.58 | 2.11 |
| Becton, Dickinson and Company (BDX)vs › | $52.98B | 0.76 | 0.79 | 0.73 | 0.74 |
| Cencora, Inc. (COR)vs › | $54.80B | 7.13 | 8.71 | 10.16 | 17.42 |
| Humana Inc. (HUM)vs › | $45.53B | 0.73 | 0.74 | 0.75 | 0.72 |
| IDEXX Laboratories, Inc. (IDXX)vs › | $44.24B | 0.67 | 0.65 | 1.10 | 1.25 |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $63.06B | 0.09 | 0.09 | 0.10 | 0.13 |
| Agilent Technologies, Inc. (A)vs › | $36.67B | 0.50 | 0.55 | 0.53 | 0.52 |
| Zoetis Inc. (ZTS)vs › | $33.36B | 2.85 | 2.13 | 1.86 | 1.81 |
| Centene Corporation (CNC)vs › | $32.19B | 0.94 | 0.84 | 0.83 | 0.81 |
| Medline Inc. (MDLN)vs › | $30.96B | 1.17 | 1.09 | 0.79 | 0.79 |
Financial Health
Debt/Equity
-3.36
Current Ratio
0.94
Cardinal Health, Inc. Debt to Equity Ratio Formula & Definition
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Cardinal Health, Inc. Debt to Equity Ratio FAQ
- What is the debt to equity ratio for Cardinal Health, Inc. (CAH)?
- The debt to equity ratio for CAH stock is -3.36.
- Is Cardinal Health, Inc.'s debt to equity ratio high or low?
- Cardinal Health, Inc.'s debt to equity ratio of -3.36 is 259% below its 5-year average of 2.11, near the low end of its 5-year range (-3.36–3.79).
- What is the TTM average debt to equity ratio for Cardinal Health, Inc. (CAH)?
- The TTM average debt to equity ratio for CAH stock is 3.77.
- What is the 3Y average debt to equity ratio for Cardinal Health, Inc. (CAH)?
- The 3Y average debt to equity ratio for CAH stock is 2.58.
- What is the 5Y average debt to equity ratio for Cardinal Health, Inc. (CAH)?
- The 5Y average debt to equity ratio for CAH stock is 2.11.
- What is the 10Y average debt to equity ratio for Cardinal Health, Inc. (CAH)?
- The 10Y average debt to equity ratio for CAH stock is 1.43.
- What is the 15Y average debt to equity ratio for Cardinal Health, Inc. (CAH)?
- The 15Y average debt to equity ratio for CAH stock is 0.74.
- What is the 20Y average debt to equity ratio for Cardinal Health, Inc. (CAH)?
- The 20Y average debt to equity ratio for CAH stock is 0.64.
Cardinal Health, Inc. Debt to Equity Ratio History
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2021-06-30 | 3.75 |
| 2020-06-30 | 3.79 |
| 2019-06-30 | 1.27 |
| 2018-06-30 | 1.49 |
| 2017-06-30 | 1.53 |
| 2016-06-30 | 0.85 |
| 2015-06-30 | 0.88 |
| 2014-06-30 | 0.62 |
| 2013-06-30 | 0.65 |
| 2012-06-30 | 0.46 |
| 2011-06-30 | 0.43 |
| 2010-06-30 | 0.40 |
| 2009-06-30 | 0.42 |
| 2008-06-30 | 0.50 |
| 2007-06-30 | 0.47 |
| 2006-06-30 | 0.33 |
| 2005-06-30 | 0.31 |
| 2004-06-30 | 0.46 |
| 2003-06-30 | 0.35 |
| 2002-06-30 | 0.35 |
| 2001-06-30 | 0.35 |
| 2000-06-30 | 0.44 |
| 1999-06-30 | 0.35 |
| 1998-06-30 | 0.46 |
| 1997-06-30 | 0.23 |
| 1996-06-30 | 0.36 |
Related Metrics
About Cardinal Health, Inc.
Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Jason Hollar